Scientists reveal the spectacular structure of C.difficile's protective armor

The spectacular structure of the protective armor of superbug C.difficile has been revealed for the first time showing the close-knit yet flexible outer layer – like chain mail.

This assembly prevents molecules getting in and provides a new target for future treatments, according to the scientists who have uncovered it.

Publishing in Nature Communications, the team of scientists from Newcastle, Sheffield and Glasgow Universities together with colleagues from Imperial College and Diamond Light Source, outline the structure of the main protein, SlpA, that forms the links of the chain mail and how they are arranged to form a pattern and create this flexible armor. This opens the possibility of designing C. diff specific drugs to break the protective layer and create holes to allow molecules to enter and kill the cell.

Protective armor

One of the many ways that diarrhea-causing superbug Clostridioides difficile has to protect itself from antibiotics is a special layer that covers the cell of the whole bacteria - the surface layer or S-layer. This flexible armor protects against the entry of drugs or molecules released by our immune system to fight bacteria.

The team determined the structure of the proteins and how they arranged using a combination of X-ray and electron crystallography.

Corresponding author Dr Paula Salgado, Senior Lecturer in Macromolecular Crystallography who led the research at Newcastle University said: "I started working on this structure more than 10 years ago, it's been a long, hard journey but we got some really exciting results! Surprisingly, we found that the protein forming the outer layer, SlpA, packs very tightly, with very narrow openings that allow very few molecules to enter the cells. S-layer from other bacteria studied so far tend to have wider gaps, allowing bigger molecules to penetrate. This may explain the success of C.diff at defending itself against the antibiotics and immune system molecules sent to attack it.

"Excitingly, it also opens the possibility of developing drugs that target the interactions that make up the chain mail. If we break these, we can create holes that allow drugs and immune system molecules to enter the cell and kill it."

One of the current challenges in our fight against infections is the growing ability bacteria have to resist the antibiotics that we use to try to kill them. Antibiotic or more generally, antimicrobial resistance (AMR), was declared by WHO as one of the top 10 global public health threats facing humanity.

Different bacteria have different mechanisms to resist antibiotics and some have multiple ways to avoid their action – the so-called superbugs. Included in these superbugs is C. diff, a bacteria that infects the human gut and is resistant to all but three current drugs. Not only that, it actually becomes a problem when we take antibiotics, as the good bacteria in the gut are killed alongside those causing an infection and, as C. diff is resistant, it can grow and cause diseases ranging from diarrhea to death due to massive lesions in the gut. Another problem is the fact that the only way to treat C.diff is to take antibiotics, so we restart the cycle and many people get recurrent infections.

Determining the structure allows the possibility of designing C. diff-specific drugs to break the S-layer, the chainmail, and create holes to allow molecules to enter and kill the cell.

Colleagues, Dr Rob Fagan and Professor Per Bullough at the University of Sheffield carried out the electron crystallography work.

We're now looking at how our findings could be used to find new ways to treat C. diff infections such as using bacteriophages to attach to and kill C. diff cells - a promising potential alternative to traditional antibiotic drugs."

Dr Rob Fagan, University of Sheffield

From Dr Salgado's team at Newcastle University, PhD student Paola Lanzoni-Mangutchi and Dr Anna Barwinska-Sendra unraveled the structural and functional details of the building blocks and determined the overall X-ray crystal structure of SlpA. Paola said: "This has been a challenging project and we spent many hours together, culturing the difficult bug and collecting X-ray data at the Diamond Light Source synchrotron."

Dr Barwinska-Sendra added: "Working together was key to our success, it is very exciting to be part of this team and to be able to finally share our work."

Journal reference:

Lanzoni-Mangutchi, P., et al. (2022) Structure and assembly of the S-layer in C. difficile. Nature Communications.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Newcastle University. (2022, November 15). Scientists reveal the spectacular structure of C.difficile's protective armor. AZoLifeSciences. Retrieved on May 29, 2024 from

  • MLA

    Newcastle University. "Scientists reveal the spectacular structure of C.difficile's protective armor". AZoLifeSciences. 29 May 2024. <>.

  • Chicago

    Newcastle University. "Scientists reveal the spectacular structure of C.difficile's protective armor". AZoLifeSciences. (accessed May 29, 2024).

  • Harvard

    Newcastle University. 2022. Scientists reveal the spectacular structure of C.difficile's protective armor. AZoLifeSciences, viewed 29 May 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New breakthrough could accelerate drug development